Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection – a double blind, randomised controlled trial in Burkina Faso

Table 4 Health Centre treatment courses prescribed to pregnant and non-pregnant cohorts by trial arm from enrolment to ANC1 (pregnant) or FIN (non-pregnant)

Treatment	Number of treatments		Mean treatments per person		Mean treatments per 50 visits^a		Incidence ratio^b (95% CI)	P value
Treatment	Iron	Control	Iron	Control	Iron	Control
Pregnant			n = 163	n = 152	Visits = 6907	Visits = 6235
Antibiotics	92	73	0.564	0.480	0.666	0.585	1.14 (0.84–1.55)	0.411
Anti-fungals^c	16	15	0.098	0.099	0.116	0.120	0.96 (0.47–1.95)	0.916
Analgesics	107	107	0.656	0.704	0.775	0.858	0.90 (0.69–1.18)	0.454
Non-pregnant			n = 426	n = 451	Visits =26473	Visits =27633
Antibiotics	331	284	0.777	0.630	0.625	0.514	1.22 (1.04–1.43)	0.015
Anti-fungals^c	39	21	0.092	0.047	0.074	0.038	1.94 (1.14–3.30)	0.014
Analgesics	481	421	1.129	0.933	0.908	0.762	1.19 (1.05–1.36)	0.008

^aMean number of visits: 42 in pregnant and 63 in non-pregnant
^bIncidence ratio was computed using Poisson regression with the number of visits as the exposure period
^cMore than 90% of vaginal pessaries prescribed for genital tract infections

ISSN: 1741-7015